Kestra Medical Technologies (KMTS) CFO Mahboob Vaseem Sells Shares

What Happened

• Mahboob Vaseem, Chief Financial Officer of Kestra Medical Technologies (KMTS), sold a total of 18,188 shares in three open-market transactions between July 30 and August 3, 2026. The sales generated aggregate gross proceeds of $418,217.
  • 2026-07-30: 3,980 shares at a weighted average price of $22.75 — $90,561 (price range reported $22.33–$23.03). [F2]
  • 2026-07-31: 8,817 shares at a weighted average price of $22.61 — $199,344 (price range reported $22.16–$22.92). [F3]
  • 2026-08-03: 5,391 shares at a weighted average price of $23.80 — $128,312 (price range reported $23.64–$23.98). [F4]
• Per the filing footnote, these sales were nondiscretionary "sell-to-cover" transactions to satisfy tax withholding obligations tied to the vesting/settlement of restricted stock units (RSUs). [F1]

Key Details

• Transaction dates: 2026-07-30, 2026-07-31, 2026-08-03.
• Total shares sold: 18,188; total gross proceeds: $418,217.
• Prices reported as weighted averages; per-footnote ranges available for each trade (see F2–F4). The filer will provide per-price breakdown on request.
• Reason: Sell-to-cover for tax withholding on RSU vesting (nondiscretionary). [F1]
• Shares owned after the transactions: not specified in the provided filing excerpt.
• Filing date: 2026-08-03. The Form 4 covers transactions through 2026-08-03; the filing itself does not indicate a late-report flag in the provided data.

Context

• These were tax-withholding sales associated with RSU settlement (routine administrative transactions) rather than discretionary open-market exits; such sell-to-cover transactions are common and do not by themselves indicate management sentiment.
• No options were exercised here; the filer simply sold vested RSU shares to cover taxes.